-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Silence Therapeutics plc annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- Silence Therapeutics plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $12,309,000, a 35% decline year-over-year.
- Silence Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2025 was $62,271,000, a 7.9% increase from 2024.
- Silence Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was $67,640,000, a 37% decline from 2023.
- Silence Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $49,462,000, a 13% increase from 2022.